Position in QGEN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,094
-$27 QoQ
Shares Held
28
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#310
of 332 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $185,901,822 across 25 Diagnostics & Research names. QGEN ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
197,012 | $38,066,658 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
66,520 | $33,350,467 | |
| 3 | A |
Agilent Technologies, Inc.
|
214,808 | $28,532,946 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
46,428 | $24,441,556 | |
| 5 | LH |
Labcorp Holdings Inc.
|
80,594 | $22,566,320 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
61,463 | $13,939,193 | |
| 7 | DHR |
Danaher Corp /De/
|
46,092 | $8,779,604 | |
| 8 | NTRA |
Natera, Inc.
|
18,343 | $4,979,207 |
All Filings in QGEN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,094 | 28 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,121 | 28 | Shares | Sole | 2026-05-06 | |
| 2024-12-31 | $8,015 | 180 | Shares | Sole | 2025-02-06 | |
| 2023-12-31 | $493 | 11 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $39,531 | 834 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $30,313 | 589 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $18,062 | 424 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $22,698 | 466 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $16,737 | 331 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||